COVID Vax Response Still Impaired in Some MS Patients After Third Shot
Immune response was attenuated after a third COVID-19 vaccine dose for multiple sclerosis (MS) patients taking certain disease-modifying treatments, interim data from a longitudinal study showed. Two weeks after a third shot, many MS patients on anti-CD20 drugs and sphingosine-1-phosphate (S1P) receptor modulators still had significantly reduced total spike and receptor-binding domain (RBD) antibody responses, […]